NEON THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
NEON THERAPEUTICS, INC. reported Earnings Per Share, Basic and Diluted of -$0.58 per share for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-05-01
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.58.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.63.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.68.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.79.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.86.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$5.54.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$34.32.
- NEON THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$30.72.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$0.58 10-Q · filed 2020-05-01 | |||
| 2019-12-31 | -$0.63 10-K · filed 2020-03-02 | -$1.31 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.10 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.86 10-K · filed 2020-03-02 |
| 2019-09-30 | -$0.68 10-K · filed 2020-03-02 | -$1.47 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.23 10-Q · filed 2019-11-12 | -$3.06 derived: net income ÷ weighted average shares · filed 2020-05-01 |
| 2019-06-30 | -$0.79 10-K · filed 2020-03-02 | -$1.55 10-Q · filed 2019-08-06 | -$2.39 derived: net income ÷ weighted average shares · filed 2020-05-01 | -$3.06 derived: net income ÷ weighted average shares · filed 2020-05-01 |
| 2019-03-31 | -$0.76 10-Q · filed 2020-05-01 | -$1.60 derived: net income ÷ weighted average shares · filed 2020-05-01 | -$2.27 derived: net income ÷ weighted average shares · filed 2020-05-01 | -$3.96 derived: net income ÷ weighted average shares · filed 2020-05-01 |
| 2018-12-31 | -$0.84 10-K · filed 2020-03-02 | -$1.51 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$3.30 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$5.54 10-K · filed 2020-03-02 |
| 2018-09-30 | -$0.67 10-K · filed 2020-03-02 | -$2.68 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$5.55 10-Q · filed 2019-11-12 | -$9.07 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2018-06-30 | -$7.84 10-K · filed 2020-03-02 | -$17.05 10-Q · filed 2019-08-06 | -$25.93 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$35.34 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2018-03-31 | -$9.47 10-K · filed 2020-03-02 | -$18.41 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$27.96 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$35.73 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2017-12-31 | -$8.93 10-K · filed 2019-03-11 | -$18.47 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$26.16 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$34.32 10-K · filed 2019-03-11 |
| 2017-09-30 | -$9.59 10-K · filed 2019-03-11 | -$17.21 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$25.33 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$7.55 10-K · filed 2019-03-11 | -$15.62 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | -$8.10 10-K · filed 2019-03-11 | |||
| 2016-12-31 | -$30.72 10-K · filed 2019-03-11 |